vf/vf_react
4
0
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity

update pay ui

Browse Source
This commit is contained in:
zzlgreat
2025-12-05 13:29:18 +08:00
parent 20994cfb13
commit 48d9c76c5e
1008 changed files with 417880 additions and 486974 deletions
Download Patch File Download Diff File Expand all files Collapse all files

941
public/htmls/药辅微晶纤维素.html
View File

@@ -1,532 +1,441 @@
<!DOCTYPE html>
<html lang="zh-CN">
<html lang="zh-CN" data-theme="night">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>药辅微晶纤维素概念分析</title>
<link href="https://fonts.googleapis.com/css?family=Inter:300,400,500,600,700,800" rel="stylesheet" />
<!-- Font Awesome Icons -->
<script src="https://kit.fontawesome.com/1d2b6c4f81.js" crossorigin="anonymous"></script>
<!-- Tailwind CSS & DaisyUI -->
<script src="https://cdn.tailwindcss.com"></script>
<link href="https://cdn.jsdelivr.net/npm/daisyui@5/dist/full.min.css" rel="stylesheet" type="text/css" />
<!-- Custom CSS -->
<style>
body {
font-family: 'Inter', sans-serif;
background: linear-gradient(135deg, #f5f7fa 0%, #e4e8f0 100%);
}
.card-shadow {
box-shadow: 0 10px 25px rgba(0, 0, 0, 0.08);
}
.gradient-text {
background: linear-gradient(90deg, #3b82f6, #10b981);
-webkit-background-clip: text;
-webkit-text-fill-color: transparent;
}
.highlight-box {
background: linear-gradient(135deg, rgba(59, 130, 246, 0.1) 0%, rgba(16, 185, 129, 0.1) 100%);
border-left: 4px solid #3b82f6;
}
.table-container {
overflow-x: auto;
}
.table-container table {
min-width: 100%;
}
@media (max-width: 768px) {
.table-container {
font-size: 0.875rem;
}
}
</style>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>药辅微晶纤维素 - 深度行业研究报告</title>
<script src="https://cdn.jsdelivr.net/npm/alpinejs@3.x.x/dist/cdn.min.js" defer></script>
<script src="https://cdn.jsdelivr.net/npm/echarts@5.5.0/dist/echarts.min.js"></script>
<link href="https://cdn.jsdelivr.net/npm/daisyui@4.11.1/dist/full.min.css" rel="stylesheet" type="text/css" />
<script src="https://cdn.tailwindcss.com"></script>
<style>
@import url('https://fonts.googleapis.com/css2?family=Noto+Sans+SC:wght@300;400;500;700&family=Orbitron:wght@400;700&display=swap');
body {
font-family: 'Noto Sans SC', sans-serif;
background-color: #010008;
overflow: hidden;
color: #E0E0E0;
}
.font-orbitron {
font-family: 'Orbitron', sans-serif;
}
.glass-card {
background: rgba(15, 12, 41, 0.4);
backdrop-filter: blur(20px);
-webkit-backdrop-filter: blur(20px);
border: 1px solid rgba(118, 75, 224, 0.15);
border-radius: 1.5rem; /* 24px */
box-shadow: 0 8px 32px 0 rgba(31, 38, 135, 0.1);
transition: all 0.3s ease;
}
.glass-card:hover {
border: 1px solid rgba(118, 75, 224, 0.3);
transform: translateY(-4px);
box-shadow: 0 12px 40px 0 rgba(118, 75, 224, 0.1);
}
.text-glow {
text-shadow: 0 0 8px rgba(192, 132, 252, 0.6), 0 0 16px rgba(192, 132, 252, 0.4);
}
.accent-glow {
filter: drop-shadow(0 0 8px rgba(45, 212, 191, 0.7));
}
/* Animated background */
.aurora-bg {
position: fixed;
top: 0;
left: 0;
width: 100%;
height: 100%;
z-index: -1;
overflow: hidden;
}
.aurora-bg > div {
position: absolute;
border-radius: 50%;
mix-blend-mode: screen;
filter: blur(80px);
opacity: 0.6;
}
.aurora-1 {
width: 800px;
height: 800px;
background: rgba(79, 70, 229, 0.3);
animation: move1 25s infinite alternate;
}
.aurora-2 {
width: 700px;
height: 700px;
background: rgba(168, 85, 247, 0.3);
animation: move2 30s infinite alternate;
}
.aurora-3 {
width: 600px;
height: 600px;
background: rgba(29, 78, 216, 0.3);
animation: move3 28s infinite alternate;
}
@keyframes move1 {
from { transform: translate(-20vw, -20vh) rotate(0deg); }
to { transform: translate(40vw, 50vh) rotate(180deg); }
}
@keyframes move2 {
from { transform: translate(50vw, -30vh) rotate(0deg); }
to { transform: translate(10vw, 60vh) rotate(-180deg); }
}
@keyframes move3 {
from { transform: translate(80vw, 40vh) rotate(0deg); }
to { transform: translate(20vw, -40vh) rotate(360deg); }
}
/* Custom scrollbar */
::-webkit-scrollbar {
width: 8px;
}
::-webkit-scrollbar-track {
background: rgba(15, 12, 41, 0.2);
}
::-webkit-scrollbar-thumb {
background: rgba(118, 75, 224, 0.3);
border-radius: 4px;
}
::-webkit-scrollbar-thumb:hover {
background: rgba(118, 75, 224, 0.5);
}
</style>
</head>
<body class="min-h-screen p-4 md:p-8">
<div class="max-w-7xl mx-auto">
<!-- Header -->
<div class="text-center mb-10">
<h1 class="text-3xl md:text-4xl font-bold gradient-text mb-4">药辅微晶纤维素概念分析</h1>
<p class="text-gray-600 max-w-3xl mx-auto">从进口替代到产能释放，国产微晶纤维素迎来基本面驱动阶段</p>
<body class="min-h-screen">
<div class="aurora-bg">
<div class="aurora-1"></div>
<div class="aurora-2"></div>
<div class="aurora-3"></div>
</div>
<!-- 概念事件 -->
<div class="card bg-white rounded-xl card-shadow mb-8">
<div class="card-body p-6">
<h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
<i class="fas fa-calendar-alt text-blue-500 mr-2"></i> 概念事件
</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-6">
<div class="highlight-box p-4 rounded-lg">
<h3 class="font-semibold text-gray-700 mb-2">背景</h3>
<p class="text-gray-600">微晶纤维素（MCC）是固体制剂（片剂、胶囊）的核心辅料，用于填充、粘合、崩解，全球市场规模约<strong class="text-blue-600">40亿元</strong>（2023年），预计2030年达<strong class="text-green-600">46亿元</strong>（CAGR 2%）。中国长期依赖进口（美国伊士曼垄断），国产替代空间巨大。</p>
</div>
<div>
<h3 class="font-semibold text-gray-700 mb-2">催化事件</h3>
<ul class="space-y-2">
<li class="flex items-start">
<span class="bg-blue-100 text-blue-800 text-xs font-medium px-2 py-1 rounded mr-2">2024年4月</span>
<span class="text-gray-600">中美关税政策导致进口CAB价格暴涨至<strong class="text-red-600">20万元/吨</strong>（国产仅8-10万），加速国产替代。</span>
</li>
<li class="flex items-start">
<span class="bg-blue-100 text-blue-800 text-xs font-medium px-2 py-1 rounded mr-2">2024年5月</span>
<span class="text-gray-600">山河药辅新厂区<strong class="text-green-600">5000吨微晶纤维素产能</strong>投产，产能利用率超预期（<strong class="text-green-600">60-70%</strong>），订单覆盖未来半年。</span>
</li>
<li class="flex items-start">
<span class="bg-blue-100 text-blue-800 text-xs font-medium px-2 py-1 rounded mr-2">2025年6月</span>
<span class="text-gray-600">三维化学<strong class="text-green-600">1.5万吨醋酸纤维素项目</strong>（含MCC）预计2026年投产，技术突破打破伊士曼垄断。</span>
</li>
</ul>
</div>
</div>
</div>
</div>
<div class="container mx-auto p-4 sm:p-6 lg:p-8 max-h-screen overflow-y-auto">
<header class="text-center mb-12">
<h1 class="font-orbitron text-4xl md:text-6xl font-bold text-transparent bg-clip-text bg-gradient-to-r from-purple-400 via-cyan-300 to-purple-400 text-glow animate-pulse">
药辅微晶纤维素
</h1>
<p class="mt-4 text-lg text-purple-200/80">深度行业研究报告</p>
<p class="mt-2 text-sm text-cyan-200/60">北京价值前沿科技有限公司 AI投研agent：“价小前投研”</p>
</header>
<!-- 核心观点摘要 -->
<div class="card bg-white rounded-xl card-shadow mb-8">
<div class="card-body p-6">
<h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
<i class="fas fa-lightbulb text-yellow-500 mr-2"></i> 核心观点摘要
</h2>
<div class="grid grid-cols-1 md:grid-cols-3 gap-4">
<div class="bg-blue-50 p-4 rounded-lg">
<h3 class="font-semibold text-blue-700 mb-2">阶段判断</h3>
<p class="text-gray-700">药辅微晶纤维素已从<strong class="text-blue-600">"进口替代主题"</strong>进入<strong class="text-green-600">"产能释放+需求爆发"</strong>的基本面驱动阶段。</p>
</div>
<div class="bg-green-50 p-4 rounded-lg">
<h3 class="font-semibold text-green-700 mb-2">核心驱动力</h3>
<ul class="text-gray-700 space-y-1">
<li>① 国产替代（进口占比40%→20%）</li>
<li>② 植物胶囊需求激增（羟丙甲纤维素拉动MCC配套）</li>
<li>③ 新产能落地（山河药辅+三维化学）</li>
</ul>
</div>
<div class="bg-purple-50 p-4 rounded-lg">
<h3 class="font-semibold text-purple-700 mb-2">未来潜力</h3>
<p class="text-gray-700">2025-2027年国产MCC市占率有望从<strong class="text-purple-600">30%提升至50%</strong>，龙头公司利润复合增速<strong class="text-purple-600">25%+</strong>。</p>
</div>
</div>
</div>
</div>
<main class="space-y-8">
<!-- Insight Section -->
<section class="glass-card p-6 md:p-8">
<h2 class="font-orbitron text-2xl md:text-3xl font-bold mb-6 border-l-4 border-cyan-400 pl-4 text-cyan-300">概念洞察 (Concept Insight)</h2>
<div class="space-y-6 text-gray-300">
<div>
<h3 class="text-xl font-bold text-purple-300 mb-2">0. 概念事件</h3>
<p>“药辅微晶纤维素”（MCC）概念的核心是高端药用辅料的国产化替代与产业升级，其发展脉络与中国的药品审评审批制度改革，特别是仿制药一致性评价政策紧密相连。随着“仿制药一致性评价”政策的全面推行，倒逼制药企业必须采用高质量、高稳定性的药用辅料，从而为性能达标且具备成本优势的国产高端辅料打开了市场空间。微晶纤维素（MCC）作为性能优于传统淀粉类的核心固体制剂辅料，正处于这一替代浪潮的中心。</p>
</div>
<!-- 核心逻辑与市场认知分析 -->
<div class="card bg-white rounded-xl card-shadow mb-8">
<div class="card-body p-6">
<h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
<i class="fas fa-brain text-purple-500 mr-2"></i> 核心逻辑与市场认知分析
</h2>
<div class="grid grid-cols-1 md:grid-cols-3 gap-6">
<div>
<h3 class="font-semibold text-gray-700 mb-3 flex items-center">
<i class="fas fa-rocket text-blue-500 mr-2"></i> 核心驱动力
</h3>
<ul class="space-y-3">
<li class="bg-gray-50 p-3 rounded-lg">
<h4 class="font-medium text-gray-800">技术突破</h4>
<p class="text-sm text-gray-600 mt-1">山河药辅<strong>16种细分规格</strong>MCC对标国际标准，通过FDA/欧盟认证；三维化学突破<strong>CAB合成技术</strong>（万吨级产线投资2.5-3亿/万吨，建设周期1年+）。</p>
</li>
<li class="bg-gray-50 p-3 rounded-lg">
<h4 class="font-medium text-gray-800">政策催化</h4>
<p class="text-sm text-gray-600 mt-1">一致性评价+集采倒逼药企降本，国产MCC价格仅为进口<strong>30-50%</strong>（进口62元/kg vs 国产22-30元/kg）。</p>
</li>
<li class="bg-gray-50 p-3 rounded-lg">
<h4 class="font-medium text-gray-800">需求爆发</h4>
<p class="text-sm text-gray-600 mt-1">植物胶囊渗透率从<strong>5%→20%</strong>（欧美已50%），单粒胶囊需<strong>50-100mg MCC</strong>，对应新增需求<strong>万吨级</strong>。</p>
</li>
</ul>
</div>
<div>
<h3 class="font-semibold text-gray-700 mb-3 flex items-center">
<i class="fas fa-fire text-orange-500 mr-2"></i> 市场热度与情绪
</h3>
<div class="space-y-4">
<div class="bg-orange-50 p-4 rounded-lg">
<h4 class="font-medium text-gray-800 mb-2">研报密集度</h4>
<p class="text-sm text-gray-600">2024年5月后，<strong class="text-orange-600">5篇深度报告</strong>聚焦山河药辅，一致预期2025年利润<strong class="text-orange-600">1.5-1.6亿元</strong>（PE 25倍）。</p>
</div>
<div class="bg-yellow-50 p-4 rounded-lg">
<h4 class="font-medium text-gray-800 mb-2">情绪分歧</h4>
<p class="text-sm text-gray-600">部分投资者担忧<strong class="text-yellow-600">价格战</strong>（常规型号降价10-15%），但高端型号（缓控释专用）溢价稳定。</p>
</div>
</div>
</div>
<div>
<h3 class="font-semibold text-gray-700 mb-3 flex items-center">
<i class="fas fa-search text-green-500 mr-2"></i> 预期差
</h3>
<div class="space-y-4">
<div class="bg-green-50 p-4 rounded-lg">
<h4 class="font-medium text-gray-800 mb-2">被忽视点</h4>
<p class="text-sm text-gray-600">三维化学的<strong class="text-green-600">1.5万吨项目</strong>（2026年投产）可能重塑供给格局，当前市场仅关注山河药辅。</p>
</div>
<div class="bg-blue-50 p-4 rounded-lg">
<h4 class="font-medium text-gray-800 mb-2">验证数据</h4>
<p class="text-sm text-gray-600">山河药辅2024年MCC销量<strong class="text-blue-600">6845吨</strong>（+22%），出口占比<strong class="text-blue-600">30%</strong>（俄罗斯、印度订单激增）。</p>
</div>
</div>
</div>
</div>
</div>
</div>
<div>
<h3 class="text-xl font-bold text-purple-300 mb-2">1. 核心观点摘要</h3>
<p class="border-l-2 border-cyan-400 pl-4 italic">药辅微晶纤维素概念正处于由政策驱动向基本面兑现过渡的<strong>加速成长期</strong>。其核心驱动力源于仿制药一致性评价带来的<strong>强制性产业升级</strong>与显著成本优势下的<strong>进口替代</strong>双重逻辑。未来，该概念的潜力不仅在于存量市场的份额替代，更在于向<strong>植物胶囊、食品添加剂</strong>等新应用场景的拓展和产品结构的<strong>高端化</strong>。</p>
</div>
<!-- 关键催化剂与未来发展路径 -->
<div class="card bg-white rounded-xl card-shadow mb-8">
<div class="card-body p-6">
<h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
<i class="fas fa-chart-line text-green-500 mr-2"></i> 关键催化剂与未来发展路径
</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-6">
<div>
<h3 class="font-semibold text-gray-700 mb-3 flex items-center">
<i class="fas fa-clock text-blue-500 mr-2"></i> 近期催化剂（3-6个月）
</h3>
<ol class="space-y-3">
<li class="flex items-start">
<span class="bg-blue-500 text-white rounded-full w-6 h-6 flex items-center justify-center text-sm mr-2 flex-shrink-0">1</span>
<div>
<h4 class="font-medium text-gray-800">三维化学项目环评通过（2025Q3）</h4>
<p class="text-sm text-gray-600">标志国产万吨级MCC量产临近。</p>
<div>
<h3 class="text-xl font-bold text-purple-300 mb-2">2. 核心逻辑与市场认知分析</h3>
<ul class="space-y-4 list-disc list-inside">
<li><strong>核心驱动力:</strong>
<ul class="pl-6 mt-2 space-y-1 text-gray-400">
<li><strong class="text-cyan-300">政策强制驱动：</strong>仿制药一致性评价及关联审评审批制度是“发令枪”，拔高了行业准入门槛，利好头部规范企业。</li>
<li><strong class="text-cyan-300">极致性价比优势：</strong>国产MCC售价仅为进口产品的1/3至1/2（22-30元/KG vs 62-186元/KG），在集采降本背景下吸引力巨大。</li>
<li><strong class="text-cyan-300">产业升级需求：</strong>MCC在可压性、粘合性上更优，适用于直接压片等先进工艺，迎合了制剂生产技术升级趋势。</li>
</ul>
</li>
<li><strong>预期差分析:</strong>
<ul class="pl-6 mt-2 space-y-1 text-gray-400">
<li><strong class="text-purple-300">增长质量 vs. 增长速度：</strong>市场关注销量增长，但路演揭示“常规型号降价，高附加值型号有议价权”，未来增长质量（高附加值产品占比）更为关键。</li>
<li><strong class="text-purple-300">产能扩张 vs. 产能消化：</strong>市场宣传新增产能巨大，但路演显示新厂区MCC产能利用率仅60%，产能释放与完全消化存在时间差。</li>
<li><strong class="text-purple-300">单一产品逻辑 vs. 平台化逻辑：</strong>市场聚焦MCC替代故事，但龙头企业已开始布局HPMC、食品添加剂等平台化战略，市场认知可能滞后。</li>
</ul>
</li>
</ul>
</div>
<div>
<h3 class="text-xl font-bold text-purple-300 mb-2">3. 关键催化剂与未来发展路径</h3>
<div class="grid md:grid-cols-2 gap-6">
<div class="bg-black/20 p-4 rounded-xl border border-white/10">
<h4 class="font-semibold text-cyan-300 mb-2">近期催化剂 (未来3-6个月)</h4>
<ul class="list-decimal list-inside space-y-1 text-sm text-gray-400">
<li>新产能利用率从60%向80%以上提升。</li>
<li>“粉状纤维素”等高附加值新品的商业化放量。</li>
<li>“植物胶囊”及“食品级纤维素”等新应用领域的商业化突破。</li>
</ul>
</div>
<div class="bg-black/20 p-4 rounded-xl border border-white/10">
<h4 class="font-semibold text-purple-300 mb-2">长期发展路径</h4>
<ol class="list-decimal list-inside space-y-1 text-sm text-gray-400">
<li><strong>份额替代期 (当前):</strong> 凭借性价比抢占国内市场。</li>
<li><strong>产品升级期:</strong> 转向硅化微晶纤维素等高端品类。</li>
<li><strong>应用拓展期:</strong> 横向拓展至植物胶囊、食品添加剂。</li>
<li><strong>国际化时期:</strong> 凭借认证和成本优势参与全球竞争。</li>
</ol>
</div>
</div>
</div>
<div>
<h3 class="text-xl font-bold text-purple-300 mb-2">4. 产业链与核心公司深度剖析</h3>
<p><strong>产业链图谱:</strong> 上游 (木浆、棉短绒) → 中游 (微晶纤维素制造商) → 下游 (制药企业、食品企业、保健品企业)。</p>
<p class="mt-2"><strong>核心玩家 - 绝对领导者：山河药辅 (300452)</strong>，其业务高度聚焦，产销量国内第一，拥有最丰富的产品矩阵和国际认证，是概念最纯粹、最核心的标的。路演数据显示其核心产品正高速放量（销量+23%，收入+22%），强力验证了核心逻辑。</p>
</div>
<div>
<h3 class="text-xl font-bold text-purple-300 mb-2">5. 潜在风险与挑战</h3>
<ul class="list-disc list-inside space-y-2 text-gray-400">
<li><strong class="text-red-400">商业化风险:</strong> 随着竞争加剧，可能引发价格战，导致行业毛利率下滑；新产能消化不及预期将侵蚀利润。</li>
<li><strong class="text-red-400">成本风险:</strong> 上游木浆、玉米等原材料价格波动会直接影响生产成本。</li>
<li><strong class="text-red-400">政策风险:</strong> 下游药品集采政策的持续高压，可能向上游传导降价压力。</li>
</ul>
</div>
<div>
<h3 class="text-xl font-bold text-purple-300 mb-2">6. 综合结论与投资启示</h3>
<p><strong>最终看法:</strong> 药辅微晶纤维素概念已<strong>进入基本面驱动阶段</strong>，并非纯粹主题炒作，而是具备扎实产业基础的成长性机会。<strong>最具投资价值的环节是中游的龙头制造商</strong>，如山河药辅，其凭借综合优势构筑了较深的护城河。</p>
<div class="mt-4 bg-black/20 p-4 rounded-xl border border-white/10">
<h4 class="font-semibold text-cyan-300 mb-2">需重点跟踪的关键指标:</h4>
<div class="grid grid-cols-2 md:grid-cols-4 gap-2 text-center text-sm">
<div class="bg-cyan-900/50 p-2 rounded-lg"><p>产能利用率</p></div>
<div class="bg-cyan-900/50 p-2 rounded-lg"><p>产品均价与毛利率</p></div>
<div class="bg-cyan-900/50 p-2 rounded-lg"><p>高附加值产品收入占比</p></div>
<div class="bg-cyan-900/50 p-2 rounded-lg"><p>新应用领域订单</p></div>
</div>
</div>
</div>
</div>
</li>
<li class="flex items-start">
<span class="bg-blue-500 text-white rounded-full w-6 h-6 flex items-center justify-center text-sm mr-2 flex-shrink-0">2</span>
<div>
<h4 class="font-medium text-gray-800">山河药辅南区二期启动</h4>
<p class="text-sm text-gray-600">新增<strong class="text-green-600">5000吨产能</strong>（2026年释放），锁定大客户订单（如阿斯利康、辉瑞）。</p>
</section>
<!-- Bento Grid for supporting data -->
<section class="grid md:grid-cols-2 lg:grid-cols-3 gap-8">
<!-- News Data Card -->
<div class="glass-card p-6 md:col-span-1 lg:col-span-2">
<h3 class="font-orbitron text-xl font-bold mb-4 text-cyan-300">新闻情报 (News Feed)</h3>
<ul class="space-y-3 text-sm text-gray-300">
<li><strong class="text-purple-300">纤维素衍生物价格波动:</strong> 醋酸丁酸纤维素(CAB)因关税政策价格上涨，凸显纤维素衍生物产业链受宏观政策影响及国产替代的共同主题。</li>
<li><strong class="text-purple-300">相关企业产能扩张:</strong> 三维化学扩产1.5万吨纤维素项目，产品包括交联羧甲基纤维素钠，下游20%应用为医药领域。</li>
<li><strong class="text-purple-300">药辅企业动态:</strong> 山河药辅发生安全事故，但位于交联羧甲纤维素钠车间，非MCC产线，对核心逻辑影响有限。</li>
<li><strong class="text-purple-300">上游技术突破:</strong> 中科院在纤维素全碳素合成淀粉领域取得重要进展，提升了纤维素基础科学研究的关注度。</li>
</ul>
</div>
</li>
<li class="flex items-start">
<span class="bg-blue-500 text-white rounded-full w-6 h-6 flex items-center justify-center text-sm mr-2 flex-shrink-0">3</span>
<div>
<h4 class="font-medium text-gray-800">植物胶囊招标旺季</h4>
<p class="text-sm text-gray-600">2025Q4国内药企集中采购，MCC需求环比<strong class="text-green-600">+30%</strong>。</p>
</div>
</li>
</ol>
</div>
<div>
<h3 class="font-semibold text-gray-700 mb-3 flex items-center">
<i class="fas fa-road text-purple-500 mr-2"></i> 长期路径
</h3>
<div class="space-y-4">
<div class="bg-purple-50 p-4 rounded-lg">
<h4 class="font-medium text-gray-800 mb-2">2025-2026年</h4>
<p class="text-sm text-gray-600">国产替代加速（进口份额从40%降至25%），龙头市占率集中（山河药辅+三维化学合计<strong class="text-purple-600">50%+</strong>）。</p>
</div>
<div class="bg-indigo-50 p-4 rounded-lg">
<h4 class="font-medium text-gray-800 mb-2">2027年后</h4>
<p class="text-sm text-gray-600">拓展食品级MCC（肠衣、保健品），打开<strong class="text-indigo-600">百亿级</strong>增量市场。</p>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- 产业链与核心公司深度剖析 -->
<div class="card bg-white rounded-xl card-shadow mb-8">
<div class="card-body p-6">
<h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
<i class="fas fa-sitemap text-indigo-500 mr-2"></i> 产业链与核心公司深度剖析
</h2>
<div class="mb-6">
<h3 class="font-semibold text-gray-700 mb-3">产业链图谱</h3>
<div class="flex flex-col md:flex-row justify-between items-center bg-gray-50 p-4 rounded-lg">
<div class="text-center mb-4 md:mb-0">
<div class="bg-blue-100 text-blue-800 font-medium px-4 py-2 rounded-lg">上游</div>
<p class="mt-2 text-sm text-gray-600">精制棉/木浆（<strong class="text-blue-600">太阳纸业</strong>）、醋酸酐（<strong class="text-blue-600">三维化学</strong>）</p>
</div>
<div class="text-center mb-4 md:mb-0">
<i class="fas fa-arrow-right text-gray-400 text-2xl mx-2 hidden md:block"></i>
</div>
<div class="text-center mb-4 md:mb-0">
<div class="bg-green-100 text-green-800 font-medium px-4 py-2 rounded-lg">中游</div>
<p class="mt-2 text-sm text-gray-600">MCC生产（<strong class="text-green-600">山河药辅</strong>、<strong class="text-green-600">三维化学</strong>、<strong class="text-green-600">红日药业-展望药业</strong>）</p>
</div>
<div class="text-center mb-4 md:mb-0">
<i class="fas fa-arrow-right text-gray-400 text-2xl mx-2 hidden md:block"></i>
</div>
<div class="text-center">
<div class="bg-purple-100 text-purple-800 font-medium px-4 py-2 rounded-lg">下游</div>
<p class="mt-2 text-sm text-gray-600">制药（片剂/胶囊）、食品（植物胶囊、抗结剂）</p>
</div>
</div>
</div>
<!-- ECharts Card -->
<div class="glass-card p-6 md:col-span-1">
<h3 class="font-orbitron text-xl font-bold mb-4 text-cyan-300">市场规模预期</h3>
<div id="market-size-chart" style="width: 100%; height: 220px;"></div>
</div>
<!-- Roadshow Data Card -->
<div class="glass-card p-6 md:col-span-1 lg:col-span-2">
<h3 class="font-orbitron text-xl font-bold mb-4 text-cyan-300">路演纪要 (Roadshow Briefing)</h3>
<div class="space-y-3 text-sm text-gray-300">
<p><strong class="text-purple-300">山河药辅 - 关键数据验证:</strong></p>
<ul class="list-disc list-inside pl-2 space-y-2 text-gray-400">
<li><strong>销量强劲增长:</strong> 2024Q1微晶纤维素(MCC)销量<strong class="text-teal-300 accent-glow">+23%</strong>；2024全年纤维素类收入<strong class="text-teal-300 accent-glow">+22%</strong>。</li>
<li><strong>产能逐步释放:</strong> 新厂区MCC产能利用率达到<strong class="text-cyan-300">60%</strong>，发货周期从2-3个月缩短至1个月。</li>
<li><strong>价格分化:</strong> 常规型号因竞争降价，但高附加值型号（定制规格）仍有议价权。</li>
<li><strong>新应用拓展:</strong> 首次提及“植物胶囊应用”新增长点，并计划申报食品级纤维素产品。</li>
</ul>
</div>
</div>
<!-- Research Report Card -->
<div class="glass-card p-6 md:col-span-1">
<h3 class="font-orbitron text-xl font-bold mb-4 text-cyan-300">研报精粹 (Research Highlights)</h3>
<ul class="space-y-3 text-sm text-gray-300">
<li><strong class="text-purple-300">替代趋势明确:</strong> 高质量MCC正逐步替代低端淀粉类辅料。</li>
<li><strong class="text-purple-300">巨大价格优势:</strong> 国产MCC (22-30元/KG) 显著低于进口 (62元/KG以上)。</li>
<li><strong class="text-purple-300">龙头地位巩固:</strong> 山河药辅新增5000吨MCC产能，总产能达14,506吨 (+52.63%)，规模优势进一步扩大。</li>
<li><strong class="text-purple-300">高成长预期:</strong> 预计2023-2025年，山河药辅纤维素类产品增速保持在15%以上，毛利率稳定在35%。</li>
</ul>
</div>
</section>
<!-- Stock Table Section -->
<section class="glass-card p-6 md:p-8">
<h2 class="font-orbitron text-2xl md:text-3xl font-bold mb-6 border-l-4 border-cyan-400 pl-4 text-cyan-300">核心标的清单 (Core Stocks)</h2>
<div class="overflow-x-auto">
<table class="table table-zebra w-full">
<thead class="text-base text-purple-300">
<tr>
<th class="bg-transparent">股票名称</th>
<th class="bg-transparent">股票代码</th>
<th class="bg-transparent">核心逻辑</th>
<th class="bg-transparent">标签</th>
</tr>
</thead>
<tbody class="text-gray-300">
<tr class="hover:bg-purple-900/20">
<td class="font-bold bg-transparent">山河药辅</td>
<td class="bg-transparent"><a href="https://valuefrontier.cn/company?scode=300452" target="_blank" class="text-cyan-400 hover:text-cyan-200">300452</a></td>
<td class="bg-transparent">公司微晶纤维素产销量居国内首位，产能5000吨/年（注：研报指新增后总产能达14506吨）</td>
<td class="bg-transparent"><span class="badge badge-primary badge-outline">产品</span></td>
</tr>
<tr class="hover:bg-purple-900/20">
<td class="font-bold bg-transparent">山东赫达</td>
<td class="bg-transparent"><a href="https://valuefrontier.cn/company?scode=002810" target="_blank" class="text-cyan-400 hover:text-cyan-200">002810</a></td>
<td class="bg-transparent">医药级纤维素醚是一种优质药用辅料，公司为行业内仅有的全产业链一体化企业；产能巨大。</td>
<td class="bg-transparent"><span class="badge badge-secondary badge-outline">纤维素醚(医用级)</span></td>
</tr>
<tr class="hover:bg-purple-900/20">
<td class="font-bold bg-transparent">红日药业</td>
<td class="bg-transparent"><a href="https://valuefrontier.cn/company?scode=300026" target="_blank" class="text-cyan-400 hover:text-cyan-200">300026</a></td>
<td class="bg-transparent">全资子公司展望药业产品包括微晶纤维素</td>
<td class="bg-transparent"><span class="badge badge-primary badge-outline">产品</span></td>
</tr>
<tr class="hover:bg-purple-900/20">
<td class="font-bold bg-transparent">尔康制药</td>
<td class="bg-transparent"><a href="https://valuefrontier.cn/company?scode=300267" target="_blank" class="text-cyan-400 hover:text-cyan-200">300267</a></td>
<td class="bg-transparent">药用辅料品种包括微晶纤维素</td>
<td class="bg-transparent"><span class="badge badge-primary badge-outline">产品</span></td>
</tr>
<tr class="hover:bg-purple-900/20">
<td class="font-bold bg-transparent">九典制药</td>
<td class="bg-transparent"><a href="https://valuefrontier.cn/company?scode=300705" target="_blank" class="text-cyan-400 hover:text-cyan-200">300705</a></td>
<td class="bg-transparent">已成功开发和生产药用辅料包括微晶纤维素</td>
<td class="bg-transparent"><span class="badge badge-primary badge-outline">产品</span></td>
</tr>
<tr class="hover:bg-purple-900/20">
<td class="font-bold bg-transparent">太阳纸业</td>
<td class="bg-transparent"><a href="https://valuefrontier.cn/company?scode=002078" target="_blank" class="text-cyan-400 hover:text-cyan-200">002078</a></td>
<td class="bg-transparent">研发项目涉及突破高性能药用微晶纤维素制备技术，为潜在进入者。</td>
<td class="bg-transparent"><span class="badge badge-accent badge-outline">研发技术</span></td>
</tr>
<tr class="hover:bg-purple-900/20">
<td class="font-bold bg-transparent">西点药业</td>
<td class="bg-transparent"><a href="https://valuefrontier.cn/company?scode=301130" target="_blank" class="text-cyan-400 hover:text-cyan-200">301130</a></td>
<td class="bg-transparent">公司致力于微晶纤维素等多糖类药用辅料的开发</td>
<td class="bg-transparent"><span class="badge badge-accent badge-outline">研发技术</span></td>
</tr>
<tr class="hover:bg-purple-900/20">
<td class="font-bold bg-transparent">恒逸石化</td>
<td class="bg-transparent"><a href="https://valuefrontier.cn/company?scode=000703" target="_blank" class="text-cyan-400 hover:text-cyan-200">000703</a></td>
<td class="bg-transparent">拥有“一种微晶纤维素改性聚酯纤维及其制备方法”相关专利</td>
<td class="bg-transparent"><span class="badge badge-accent badge-outline">研发技术</span></td>
</tr>
<tr class="hover:bg-purple-900/20">
<td class="font-bold bg-transparent">宣泰医药</td>
<td class="bg-transparent"><a href="https://valuefrontier.cn/company?scode=688247" target="_blank" class="text-cyan-400 hover:text-cyan-200">688247</a></td>
<td class="bg-transparent">拥有“一种微晶纤维素的制备方法”相关专利</td>
<td class="bg-transparent"><span class="badge badge-accent badge-outline">研发技术</span></td>
</tr>
</tbody>
</table>
</div>
</section>
</main>
<div>
<h3 class="font-semibold text-gray-700 mb-3">核心玩家对比</h3>
<div class="table-container">
<table class="min-w-full bg-white border border-gray-200 rounded-lg overflow-hidden">
<thead class="bg-gray-50">
<tr>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">公司</th>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">产能（吨）</th>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">技术壁垒</th>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">客户绑定</th>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">风险点</th>
</tr>
</thead>
<tbody class="divide-y divide-gray-200">
<tr>
<td class="py-3 px-4 font-medium text-gray-900">山河药辅</td>
<td class="py-3 px-4 text-gray-700"><strong class="text-green-600">14500</strong>（2025年）</td>
<td class="py-3 px-4 text-gray-700">16种细分规格，FDA认证</td>
<td class="py-3 px-4 text-gray-700">辉瑞、赛诺菲全球供应商</td>
<td class="py-3 px-4 text-gray-700">新产能爬坡不及预期</td>
</tr>
<tr>
<td class="py-3 px-4 font-medium text-gray-900">三维化学</td>
<td class="py-3 px-4 text-gray-700"><strong class="text-green-600">15000</strong>（2026年）</td>
<td class="py-3 px-4 text-gray-700">CAB合成技术突破</td>
<td class="py-3 px-4 text-gray-700">国内药企集采订单</td>
<td class="py-3 px-4 text-gray-700">项目延期或成本超支</td>
</tr>
<tr>
<td class="py-3 px-4 font-medium text-gray-900">红日药业</td>
<td class="py-3 px-4 text-gray-700"><strong class="text-green-600">3000</strong>（子公司）</td>
<td class="py-3 px-4 text-gray-700">低端MCC为主</td>
<td class="py-3 px-4 text-gray-700">国内中小药企</td>
<td class="py-3 px-4 text-gray-700">价格战挤压利润</td>
</tr>
</tbody>
</table>
</div>
</div>
<div class="mt-6 grid grid-cols-1 md:grid-cols-2 gap-4">
<div class="bg-green-50 p-4 rounded-lg">
<h4 class="font-medium text-gray-800 mb-2 flex items-center">
<i class="fas fa-check-circle text-green-500 mr-2"></i> 印证
</h4>
<p class="text-sm text-gray-600">山河药辅2024年MCC收入<strong class="text-green-600">2.35亿元</strong>（+18%），毛利率<strong class="text-green-600">36%</strong>（高于行业平均25%）。</p>
</div>
<div class="bg-red-50 p-4 rounded-lg">
<h4 class="font-medium text-gray-800 mb-2 flex items-center">
<i class="fas fa-exclamation-circle text-red-500 mr-2"></i> 风险
</h4>
<p class="text-sm text-gray-600">三维化学项目若延期，2026年供给缺口或导致进口依赖反弹。</p>
</div>
</div>
</div>
<footer class="text-center mt-12 pb-4">
<p class="text-xs text-gray-500">本报告为AI合成数据，信息来源于公开渠道，可能存在时效性、准确性等风险，不构成任何投资建议，投资需谨慎。</p>
</footer>
</div>
<script>
document.addEventListener('DOMContentLoaded', function () {
var chartDom = document.getElementById('market-size-chart');
var myChart = echarts.init(chartDom);
var option;
<!-- 潜在风险与挑战 -->
<div class="card bg-white rounded-xl card-shadow mb-8">
<div class="card-body p-6">
<h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
<i class="fas fa-exclamation-triangle text-red-500 mr-2"></i> 潜在风险与挑战
</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4">
<div class="bg-red-50 p-4 rounded-lg">
<h3 class="font-semibold text-red-700 mb-2">技术风险</h3>
<p class="text-gray-700">三维化学的<strong>CAB工艺稳定性</strong>需验证（专家纪要提示"建设周期1年+，调试风险高"）。</p>
</div>
<div class="bg-orange-50 p-4 rounded-lg">
<h3 class="font-semibold text-orange-700 mb-2">商业化风险</h3>
<p class="text-gray-700">常规MCC价格战（2024年降价10-15%），高端型号占比不足30%。</p>
</div>
<div class="bg-yellow-50 p-4 rounded-lg">
<h3 class="font-semibold text-yellow-700 mb-2">政策风险</h3>
<p class="text-gray-700">若FDA收紧进口辅料认证，国产MCC出口或受阻。</p>
</div>
<div class="bg-purple-50 p-4 rounded-lg">
<h3 class="font-semibold text-purple-700 mb-2">信息矛盾</h3>
<p class="text-gray-700">路演称"订单覆盖半年"，但2025Q1收入增速仅<strong class="text-purple-600">4.28%</strong>（需跟踪库存消化进度）。</p>
</div>
</div>
</div>
</div>
option = {
tooltip: {
trigger: 'axis',
axisPointer: {
type: 'shadow'
},
backgroundColor: 'rgba(15, 12, 41, 0.8)',
borderColor: 'rgba(118, 75, 224, 0.5)',
textStyle: {
color: '#E0E0E0'
}
},
grid: {
left: '3%',
right: '4%',
bottom: '3%',
containLabel: true
},
xAxis: [
{
type: 'category',
data: ['2016', '2021', '2025 (预期)'],
axisTick: {
alignWithLabel: true
},
axisLine: {
lineStyle: {
color: 'rgba(255, 255, 255, 0.2)'
}
},
axisLabel: {
color: '#a5b4fc'
}
}
],
yAxis: [
{
type: 'value',
name: '亿元',
axisLine: {
show: true,
lineStyle: {
color: 'rgba(255, 255, 255, 0.2)'
}
},
axisLabel: {
color: '#a5b4fc'
},
splitLine: {
lineStyle: {
color: 'rgba(255, 255, 255, 0.05)'
}
}
}
],
series: [
{
name: '市场规模',
type: 'bar',
barWidth: '60%',
data: [
{ value: 469, itemStyle: { color: '#38bdf8' } },
{ value: 846, itemStyle: { color: '#6366f1' } },
{
value: 1406,
itemStyle: {
color: new echarts.graphic.LinearGradient(0, 0, 0, 1, [
{ offset: 0, color: '#a78bfa' },
{ offset: 1, color: '#6366f1' }
])
}
}
],
label: {
show: true,
position: 'top',
color: '#fff',
formatter: '{c}'
}
}
]
};
myChart.setOption(option);
window.addEventListener('resize', myChart.resize);
});
</script>
<!-- 综合结论与投资启示 -->
<div class="card bg-gradient-to-r from-blue-500 to-green-500 rounded-xl card-shadow mb-8 text-white">
<div class="card-body p-6">
<h2 class="text-xl font-bold mb-4 flex items-center">
<i class="fas fa-trophy text-yellow-300 mr-2"></i> 综合结论与投资启示
</h2>
<div class="grid grid-cols-1 md:grid-cols-3 gap-6">
<div>
<h3 class="font-semibold mb-2">阶段判断</h3>
<p class="text-blue-100"><strong class="text-yellow-300">基本面驱动初期</strong>（产能释放+需求爆发），非主题炒作。</p>
</div>
<div>
<h3 class="font-semibold mb-2">投资方向</h3>
<ul class="space-y-2 text-blue-100">
<li><strong class="text-yellow-300">首选</strong>：<strong class="text-yellow-300">山河药辅</strong>（产能落地+客户验证完成，2025年PE 20倍，低于历史中枢）</li>
<li><strong class="text-yellow-300">弹性标的</strong>：<strong class="text-yellow-300">三维化学</strong>（万吨级项目催化，2026年业绩弹性大）</li>
</ul>
</div>
<div>
<h3 class="font-semibold mb-2">跟踪指标</h3>
<ol class="space-y-1 text-blue-100">
<li>1. <strong class="text-yellow-300">月度出口数据</strong>（海关代码：39129000）</li>
<li>2. <strong class="text-yellow-300">山河药辅南区产能利用率</strong>（目标2025Q4达<strong class="text-yellow-300">80%+</strong>）</li>
<li>3. <strong class="text-yellow-300">植物胶囊招标价格</strong>（MCC成本占比<strong class="text-yellow-300">5-10%</strong>，敏感度极高）</li>
</ol>
</div>
</div>
</div>
</div>
<!-- 关联股票数据 -->
<div class="card bg-white rounded-xl card-shadow mb-8">
<div class="card-body p-6">
<h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
<i class="fas fa-chart-bar text-indigo-500 mr-2"></i> 关联股票数据
</h2>
<div class="table-container">
<table class="min-w-full bg-white border border-gray-200 rounded-lg overflow-hidden">
<thead class="bg-gray-50">
<tr>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">股票名称</th>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">分类</th>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">行业</th>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">项目</th>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">产业链</th>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">信息来源</th>
<th class="py-3 px-4 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">关联原因</th>
</tr>
</thead>
<tbody class="divide-y divide-gray-200">
<tr>
<td class="py-3 px-4 font-medium text-gray-900">山河药辅</td>
<td class="py-3 px-4 text-gray-700">产品</td>
<td class="py-3 px-4 text-gray-700">药用辅料</td>
<td class="py-3 px-4 text-gray-700">微晶纤维素生产</td>
<td class="py-3 px-4 text-gray-700">生产制造</td>
<td class="py-3 px-4 text-gray-700">年报/公告</td>
<td class="py-3 px-4 text-gray-700">公司微晶纤维素产销量居国内首位，产能5000吨/年</td>
</tr>
<tr>
<td class="py-3 px-4 font-medium text-gray-900">红日药业</td>
<td class="py-3 px-4 text-gray-700">产品</td>
<td class="py-3 px-4 text-gray-700">药用辅料</td>
<td class="py-3 px-4 text-gray-700">子公司展望药业生产微晶纤维素</td>
<td class="py-3 px-4 text-gray-700">生产制造</td>
<td class="py-3 px-4 text-gray-700">公告</td>
<td class="py-3 px-4 text-gray-700">全资子公司展望药业产品包括微晶纤维素</td>
</tr>
<tr>
<td class="py-3 px-4 font-medium text-gray-900">尔康制药</td>
<td class="py-3 px-4 text-gray-700">产品</td>
<td class="py-3 px-4 text-gray-700">药用辅料</td>
<td class="py-3 px-4 text-gray-700">药用辅料生产</td>
<td class="py-3 px-4 text-gray-700">生产制造</td>
<td class="py-3 px-4 text-gray-700">年报</td>
<td class="py-3 px-4 text-gray-700">药用辅料品种包括微晶纤维素</td>
</tr>
<tr>
<td class="py-3 px-4 font-medium text-gray-900">九典制药</td>
<td class="py-3 px-4 text-gray-700">产品</td>
<td class="py-3 px-4 text-gray-700">药用辅料</td>
<td class="py-3 px-4 text-gray-700">药用辅料开发</td>
<td class="py-3 px-4 text-gray-700">生产制造</td>
<td class="py-3 px-4 text-gray-700">年报</td>
<td class="py-3 px-4 text-gray-700">已成功开发生产药用辅料包括微晶纤维素</td>
</tr>
<tr>
<td class="py-3 px-4 font-medium text-gray-900">太阳纸业</td>
<td class="py-3 px-4 text-gray-700">研发技术</td>
<td class="py-3 px-4 text-gray-700">药用辅料</td>
<td class="py-3 px-4 text-gray-700">高性能药用微晶纤维素制备技术</td>
<td class="py-3 px-4 text-gray-700">技术研发</td>
<td class="py-3 px-4 text-gray-700">年报</td>
<td class="py-3 px-4 text-gray-700">研发项目涉及突破高性能药用微晶纤维素制备技术</td>
</tr>
<tr>
<td class="py-3 px-4 font-medium text-gray-900">恒逸石化</td>
<td class="py-3 px-4 text-gray-700">研发技术</td>
<td class="py-3 px-4 text-gray-700">材料科学</td>
<td class="py-3 px-4 text-gray-700">微晶纤维素改性聚酯纤维制备</td>
<td class="py-3 px-4 text-gray-700">技术研发</td>
<td class="py-3 px-4 text-gray-700">公告</td>
<td class="py-3 px-4 text-gray-700">一种微晶纤维素改性聚酯纤维及其制备方法</td>
</tr>
<tr>
<td class="py-3 px-4 font-medium text-gray-900">宣泰医药</td>
<td class="py-3 px-4 text-gray-700">研发技术</td>
<td class="py-3 px-4 text-gray-700">药用辅料</td>
<td class="py-3 px-4 text-gray-700">微晶纤维素制备方法</td>
<td class="py-3 px-4 text-gray-700">技术研发</td>
<td class="py-3 px-4 text-gray-700">公告</td>
<td class="py-3 px-4 text-gray-700">一种微晶纤维素的制备方法</td>
</tr>
<tr>
<td class="py-3 px-4 font-medium text-gray-900">西点药业</td>
<td class="py-3 px-4 text-gray-700">研发技术</td>
<td class="py-3 px-4 text-gray-700">药用辅料</td>
<td class="py-3 px-4 text-gray-700">多糖类药用辅料开发</td>
<td class="py-3 px-4 text-gray-700">技术研发</td>
<td class="py-3 px-4 text-gray-700">公告</td>
<td class="py-3 px-4 text-gray-700">致力于微晶纤维素等多糖类药用辅料的开发</td>
</tr>
<tr>
<td class="py-3 px-4 font-medium text-gray-900">山东赫达</td>
<td class="py-3 px-4 text-gray-700">纤维素醚（医用级）</td>
<td class="py-3 px-4 text-gray-700">药用辅料</td>
<td class="py-3 px-4 text-gray-700">医药级纤维素醚生产</td>
<td class="py-3 px-4 text-gray-700">全产业链</td>
<td class="py-3 px-4 text-gray-700">公告</td>
<td class="py-3 px-4 text-gray-700">医药级纤维素醚为优质药用辅料，设计产能8.5万吨/年（已投产7.4万吨/年），行业唯一全产业链一体化企业</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
</div>
<!-- 背景动画 -->
<script src="https://cdn.jsdelivr.net/npm/tsparticles@3/tsparticles.bundle.min.js"></script>
<script>
tsParticles.load("tsparticles", {
background: {
color: {
value: "transparent",
},
},
fpsLimit: 60,
particles: {
color: {
value: ["#3b82f6", "#10b981", "#8b5cf6"],
},
links: {
color: "#9ca3af",
distance: 150,
enable: true,
opacity: 0.2,
width: 1,
},
move: {
direction: "none",
enable: true,
outModes: {
default: "bounce",
},
random: true,
speed: 1,
straight: false,
},
number: {
density: {
enable: true,
area: 800,
},
value: 30,
},
opacity: {
value: 0.3,
},
shape: {
type: "circle",
},
size: {
value: { min: 1, max: 3 },
},
},
detectRetina: true,
});
</script>
<div id="tsparticles" class="fixed inset-0 -z-10"></div>
</body>
</html>
```
</html>